Results 131 to 140 of about 4,410 (179)

A Dihydroergotamine Autoinjector (Brekiya) for Migraine

The Medical Letter on Drugs and Therapeutics
The FDA has approved Brekiya (Amneal), the first dihydroergotamine (DHE) autoinjector product. DHE has been available for IV, IM, SC and intranasal administration (Trudhesa,1 and others). Like other parenteral DHE products, Brekiya is indicated for the acute treatment of migraine, with or without aura, and cluster headache in adults.
openaire   +2 more sources

Epinephrine autoinjectors on airplanes

Annals of Allergy, Asthma & Immunology, 2020
Maeve, O'Connor, Tonya, Winders, J Allen, Meadows   +2 more
openaire   +2 more sources

Epinephrine autoinjectors available in Canada

2023
Therapeutics Letter 119 discusses epinephrine autoinjectors available in Canada. Conclusions People at risk for anaphylaxis in the outpatient setting should be advised to have access to at least two epinephrine autoinjectors especially when they are far from emergency medical care (home, travel, occupation, recreational activities).
openaire   +1 more source

Epinephrine autoinjectors

Annals of Allergy, Asthma & Immunology, 2020
Sten Dreborg, Harold Kim
openaire   +1 more source

Acceptability of Cyltezo pen among biologics autoinjector patients, autoinjector naïve patients, and healthcare professionals

Expert Opinion on Drug Delivery
Cyltezo® (Adalimumab-adbm) is an FDA-approved interchangeable biosimilar for Humira® (adalimumab reference product [RP]) that helps treat chronic inflammatory conditions. Adalimumab-adbm is administered via an autoinjector, the adalimumab-adbm pen. This study assessed user opinions related to usability, perceptions, convenience, safety features, and ...
Raul, Perez, Julie D, Suman, Joe, Reynolds   +2 more
openaire   +2 more sources

Epinephrine autoinjectors

Annals of Allergy, Asthma & Immunology, 2023
openaire   +1 more source

The importance of adrenaline autoinjector

Medicína pro praxi, 2023
openaire   +1 more source

Formative and Validation Human Factors studies of a new disposable autoinjector for subcutaneous delivery of chronic disease therapies

Expert Opinion on Drug Delivery, 2021
Anne Combedazou, Stanislav Glezer, Karen Guerrero   +2 more
exaly  

A Cost-Effectiveness Analysis of Epinephrine Autoinjector Risk Stratification for Patients with Food Allergy—One Epinephrine Autoinjector or Two?

Journal of Allergy and Clinical Immunology: in Practice, 2021
Paul J Turner, Matthew J Greenhawt, Marcus Shaker   +2 more
exaly  

Adrenaline autoinjector is underprescribed in typical cold urticaria patients

Allergy: European Journal of Allergy and Clinical Immunology, 2022
Dejan Dinevski, Solange Oliveira Rodrigues Valle   +1 more
exaly